Search Results - "Radaoui, Alexander B"

Surface and Global Proteome Analyses Identify ENPP1 and Other Surface Proteins as Actionable Immunotherapeutic Targets in Ewing Sarcoma by Mooney, Brian, Negri, Gian Luca, Shyp, Taras, Delaidelli, Alberto, Zhang, Hai-Feng, Spencer Miko, Sandra E, Weiner, Amber K, Radaoui, Alexander B, Shraim, Rawan, Lizardo, Michael M, Hughes, Christopher S, Li, Amy, El-Naggar, Amal M, Rouleau, Melanie, Li, Wei, Dimitrov, Dimiter S, Kurmasheva, Raushan T, Houghton, Peter J, Diskin, Sharon J, Maris, John M, Morin, Gregg B, Sorensen, Poul H

“…Ewing sarcoma is the second most common bone sarcoma in children, with 1 case per 1.5 million in the United States. Although the survival rate of patients…”
Get full text

Abstract 3650: Integrative mass spectrometry and RNA-sequencing identifies DLK1 as a candidate immunotherapeutic target in neuroblastoma by Weiner, Amber K., Radaoui, Alexander B., Kendsersky, Nathan M., Harenza-Rokita, Jo Lynne, Sidoli, Simone, Conkrite, Karina L., Vaksman, Zalman, Rathi, Komal, Raman, Pichai, Martinez, Daniel, Bhatti, Tricia, Tsang, Matthew, Pawel, Bruce, Garcia, Benjamin A., Maris, John M., Diskin, Sharon J.

“…Abstract BACKGROUND. Neuroblastoma (NB) is an embryonal tumor of the sympathetic nervous system that accounts for 12% of childhood cancer deaths. Despite…”
Get full text

Abstract LB-B04: A multi-omic surfaceome study identifies DLK1 as an epigenetically regulated protein and immunotherapeutic target in neuroblastoma by Weiner, Amber K., Radaoui, Alexander B., Tsang, Matthew, Martinez, Dan, Sidoli, Simone, Conkrite, Karina L., Delaidelli, Alberto, Rokita, Jo Lynne, Lane, Maria V., Vaksman, Zalman, Rathi, Komal S., Raman, Pichai, Pogoriler, Jennifer, Bhatti, Tricia, Pawel, Bruce, Teicher, Beverly, Erickson, Stephen W., Sorensen, Poul, Mosse, Yael P., Krytska, Kateryna, Zammarchi, Francesca, Berkel, Patrick H. van, Smith, Malcolm A., Garcia, Benjamin A., Maris, John M., Diskin, Sharon J.

“…Abstract Background: Neuroblastoma (NB) is an embryonal tumor of the sympathetic nervous system that accounts for 12% of childhood cancer deaths. While the…”
Get full text

Abstract 1090: GPC2 directed CAR T cells are efficacious against fusion-positive and fusion-negative rhabdomyosarcomas by Shraim, Rawan, Schuerch, Patrick M., Giudice, Anna Maria, Conkrite, Karina L., Weiner, Amber K., Radaoui, Alexander B., Mooney, Brian, Kurmasheva, Raushan T., Houghton, Peter J., Morin, Gregg B., Mosse, Yael B., Sorensen, Poul H., Garcia, Benjamin A., Sacan, Ahmet, Maris, John M., Bosse, Kristopher R., Diskin, Sharon J.

“…Abstract Background: Rhabdomyosarcoma (RMS) is an aggressive pediatric solid tumor with poor survival and new targeted therapies are needed. Aims: Using an…”
Get full text

Abstract A009: Proteogenomic prioritization of immunotherapeutic targets in rhabdomyosarcoma nominate MEGF10 for preclinical development by Shraim, Rawan, Weiner, Amber K., Conkrite, Karina L., Radaoui, Alexander B., Maris, John M., Mosse, Yael P., Diskin, Sharon J., Sacan, Ahmet, Garcia, Benjamin A., Houghton, Peter J., Kurmasheva, Raushan T., Sorensen, Poul, Morin, Gregg B., Mooney, Brian

“…Abstract Background: Rhabdomyosarcoma (RMS) has a high unmet need in terms of precision therapy development as there are currently no approved immunotherapies…”
Get full text

Abstract 4515: PIONEER: harnessing multi-omics data to enhance immunotherapeutic target discovery and development by Weiner, Amber K., Murali, Hemma, Shraim, Rawan, Conkrite, Karina L., Radaoui, Alexander B., Martinez, Daniel, Mooney, Brian, Spencer Miko, Sandra E., Negri, Gian, Delaidelli, Alberto, de Jong, Caitlyn, Zhu, Yuankun, Heath, Allison P., Pogoriler, Jennifer, Mosse, Yael P., Taylor, Deanne M., Sorensen, Poul H., Morin, Gregg B., Garcia, Benjamin A., Maris, John M., Diskin, Sharon J.

“…Abstract Introduction: Immunotherapeutic strategies have produced remarkable results in some malignancies. However, optimal cell surface targets in many…”
Get full text